220460-98-0 Usage
Uses
Used in Pharmaceutical Industry:
CPB is used as a drug candidate for the development of therapeutic agents targeting various diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its anti-cancer properties make it a potential candidate for the treatment of various types of cancer, while its anti-inflammatory effects may be beneficial in managing autoimmune disorders.
Used in Drug Development Research:
CPB is utilized in research for its potential to inhibit specific enzymes and cellular pathways, which could lead to the development of new drugs for the treatment of various diseases. Its unique molecular structure and biological activities make it an interesting compound for further investigation and potential pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 220460-98-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,4,6 and 0 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 220460-98:
(8*2)+(7*2)+(6*0)+(5*4)+(4*6)+(3*0)+(2*9)+(1*8)=100
100 % 10 = 0
So 220460-98-0 is a valid CAS Registry Number.
220460-98-0Relevant academic research and scientific papers
Vasopressin agonist formulation and process
-
Page/Page column 41, (2010/02/09)
This invention provides novel formulations for vasopressin agonist compounds, or a pharmaceutically acceptable salt thereof, having the general structure: and processes for making them, the formulations comprising from about 1% to about 20% of active ingredient, from about 1% to about 18% of a surfactant component, from about 50% to about 80% of a component of one or more polyethylene glycols, from about 1% to about 20% of a component of one or more sucrose fatty acid esters and/or polyvinylpyrrolidone and, optionally, one or more preservatives or antioxidants.
Tricyclic vasopressin agonists
-
, (2008/06/13)
This invention relates to new compounds selected from those of the general formula (I), or a pharmaceutically acceptable salt, ester or prodrug form thereof: wherein D, E and G are N or CH, which serve as vasopressin agonists and are useful in treating disorders such as diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, bleeding and coagulation disorders, and the inability to temporarily delay urination and pharmaceutical compositions and methods for same.
